Canada markets closed

Supernus Pharmaceuticals, Inc. (SUPN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
30.08-0.02 (-0.07%)
At close: 04:00PM EDT
30.08 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.65B
Enterprise Value 1.44B
Trailing P/E 1.50k
Forward P/E 20.16
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.75
Price/Book (mrq)1.80
Enterprise Value/Revenue 2.37
Enterprise Value/EBITDA 16.00

Trading Information

Stock Price History

Beta (5Y Monthly) 0.99
52-Week Change 3-19.13%
S&P500 52-Week Change 323.10%
52 Week High 338.09
52 Week Low 321.99
50-Day Moving Average 331.48
200-Day Moving Average 329.08

Share Statistics

Avg Vol (3 month) 3393.23k
Avg Vol (10 day) 3319.49k
Shares Outstanding 554.97M
Implied Shares Outstanding 654.97M
Float 847.71M
% Held by Insiders 15.02%
% Held by Institutions 1107.88%
Shares Short (Apr 15, 2024) 44.68M
Short Ratio (Apr 15, 2024) 410.84
Short % of Float (Apr 15, 2024) 412.88%
Short % of Shares Outstanding (Apr 15, 2024) 48.55%
Shares Short (prior month Mar 15, 2024) 44.92M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.22%
Operating Margin (ttm)11.56%

Management Effectiveness

Return on Assets (ttm)0.56%
Return on Equity (ttm)0.15%

Income Statement

Revenue (ttm)607.52M
Revenue Per Share (ttm)11.14
Quarterly Revenue Growth (yoy)-1.80%
Gross Profit (ttm)N/A
EBITDA 98.26M
Net Income Avi to Common (ttm)1.32M
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)-95.40%

Balance Sheet

Total Cash (mrq)254.87M
Total Cash Per Share (mrq)4.66
Total Debt (mrq)41.53M
Total Debt/Equity (mrq)4.51%
Current Ratio (mrq)1.70
Book Value Per Share (mrq)16.84

Cash Flow Statement

Operating Cash Flow (ttm)111.08M
Levered Free Cash Flow (ttm)161.71M